Earnings Call · Q2 FY2023·2023-10-30

Q2 23EPS -100.00%*·Rev n/aQ1 23EPS +42.86%·Rev n/aQ4 22EPS -100.00%*·Rev n/aQ3 22EPS -88.24%·Rev n/a⚠ consensus missing

PETMED EXPRESS INC PETS

Brian Prenoveau — Investor Relations

Matthew Hulett — Chief Executive Officer

Unknown

Christine Chambers — Chief Financial Officer

−24.9%1d on move date−25.6% vs SPY3d−21.7%5d−22.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PETS calls or request research access.

More PETS calls Browse calls Request research access